Midol Complete, Acetaminophen, Caffeine, Pyrilamine Maleate, Caplets, OTC, a) 16 ct. blister (NDC 0280-8005-16), b)24 ct. blister, Distributed by Bayer Health Care, Morristown, NJ 07962 (NDC 0280-8005-25)
Published July 25, 2012 · Recall initiated: April 26, 2012
Summary
FDA records drug Class III recall D-1424-2012, published July 25, 2012 and initiated April 26, 2012. Recalling firm: Bayer Healthcare, LLC; Status: Terminated; Reported quantity: 48,528 cartons; Lot: NAA055N Exp.12/13, NAA05PC Exp.12/13, NAA0462 Exp.12/13. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Label Mix-up: This recall was initiated after identifying that the label statement on the blister strip regarding the maximum number of capsules/caplets that should be taken within a 24-hour period, does not match the statement on the carton.
What to do
Voluntary: Firm initiated · Letter
Get an email if MIDOL COMPLETE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- MIDOL COMPLETE
- Manufacturer
- Bayer Healthcare, LLC
- Distributor
- Product was distributed to 93 retail accounts/customers.
- UPC
- 0312843555198
- Lot
- NAA055N Exp.12/13, NAA05PC Exp.12/13, NAA0462 Exp.12/13
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAMidol Complete, Acetaminophen, Caffeine, Pyrilamine Maleate, Gelcaps 24 ct. blister, OTC, Distributed by BayerJuly 25, 2012
- FDASP Standard Process, Cataplex ACP (Product #0700 and 0750) , Dietary supplement, 90 & 360 Tablets, ProprietaryJuly 25, 2012
- FDACiprofloxacin Tablets, USP, 500 mg, Rx Only, 100 Tablets per Bottle, Manufactured in India by: UniqueJuly 25, 2012
- FDASP Standard Process, Cataplex C, Dietary Supplement, (Product # 1650 and 1655) , 90 & 360 Tablets, ProprietaryJuly 25, 2012
- FDAEpinephrine Injection, USP, 1:1000 (1 mg/mL), 25 x 1 mL Ampules, For SC and IM Use, For IV and IC Use afterJuly 25, 2012
- FDAStandard Process, Pancreatrophin PMG (Product # 6650), 90 Tablets, Proprietary Blend: Bovine pancreas PMGJuly 25, 2012
Questions about this recall
Was Midol Complete, Acetaminophen, Caffeine, Pyrilamine Maleate, Caplets, OTC, a) 16 ct. blister (NDC 0280-8005-16), b)24 ct. blister, Distributed by Bayer Health Care, Morristown, NJ 07962 (NDC 0280-8005-25) recalled?
Yes. FDA published recall D-1424-2012 on July 25, 2012. Reported hazard: Labeling: Label Mix-up: This recall was initiated after identifying that the label statement on the blister strip regarding the maximum number of capsules/caplets that should be taken within a 24-hour period, does not match the statement on the carton.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: MIDOL COMPLETE. UPC: 0312843555198.